XSNX DR TUTTLE//"over 900% value creation for IPO

New Post Public Reply Private Reply Replies (0) Message Board

May 21, 2013 at 2:23 PM

XSNX >>DR TUTTLE//"over 900% value creation for IPO shareholders"

Cleantech Innovator Dr. John Tuttle Joins XsunX Team
Company Strengthens Its CIGS Technological and Business Capabilities

Press Release: XsunX, Inc. – Wed, May 15, 2013 9:00 AM EDT
Email

Print
RELATED QUOTES
Symbol Price Change
XSNX 0.0148 0.00

ALISO VIEJO, CA--(Marketwired - May 15, 2013) - XsunX, Inc. (OTCQB: XSNX), the developer of CIGSolar®, a patent-pending technology for the mass production of CIGS solar cells that offers a capital-efficient, low-cost alternative to the use of silicon solar cells, today announced that the Dr. John R. Tuttle had joined the Company's Advisory Board. "John's extensive entrepreneurial background and comprehensive knowledge of the Cleantech industry is the perfect addition to XsunX at just the right time," stated XsunX CEO, Tom Djokovich.
Over the last several years, the Company has been developing its CIGSolar® technology while navigating the solar industry-wide restructuring. Recently XsunX began its transition from focusing on its CIGSolar baseline system design and build-out to marketing of its CIGSolar® technology. The next logical step was the addition of a seasoned industry innovation and business development veteran to aid in this transition and further development of XsunX's business relationships with customers and investors.
"There's been a paradigm shift occurring at virtually every level of the solar industry including, and most significantly, how business, the capital markets, and project finance assess the value of the solar industry as a whole and, more specifically, the value of any particular technology," added XsunX CEO Tom Djokovich. "Our current requirement was to find someone with world-class CIGS experience and someone who could also 'think outside of the box' -- or in the CIGS business -- outside of the vacuum chamber to commercialize technology. Dr. Tuttle's years of noteworthy experience at NREL elevating the science and capabilities of CIGS, and his experience transitioning innovation into operational results provides XsunX with the hands-on capabilities that we were looking for," concluded Mr. Djokovich.
Dr. Tuttle brings 30 years of experience in the semiconductor & photovoltaic industries to XsunX, and for the last several years has focused on assisting with operational and capital management of early-stage companies in the Cleantech sector. Previously, he was the co-founder, Chief Executive & Chairman of DayStar Technologies, Inc. where he took the company from 3 employees to an operational organization with world-class development and pilot production facilities, achieving an over 900% value creation for its IPO shareholders.
From 1986-1997, Dr. Tuttle held the position of Senior Scientist at NREL where his research guided the fabrication of thin-film CIGS PV devices with multiple world-record efficiencies. He has authored/co-authored over 70 publications, 14 Patent's / Patent applications, and conducted over 100 presentations about technology & business development. Dr. Tuttle holds a Ph.D. in EE from the University of Colorado, an M.S. from the Colorado School of Mines and a B.S in Applied and Engineering Physics from Cornell University. Dr. Tuttle is joining as Senior Scientific and Business Advisor to XsunX.
About XsunX
XsunX, Inc. is working to commercialize a new manufacturing process to produce low cost, high efficiency thin-film Copper Indium Gallium (di) Selenide (CIGS) thin film solar cells. Our patent-pending processing technology, which we call CIGSolar®, focuses on the mass production of thin-film CIGS solar cells utilizing a proprietary multi-area thermal deposition process to minimize processing defects to create highly uniform CIGS films. These cells match silicon solar cell dimensions and can be offered as a non-toxic, high-efficiency and lowest-cost alternative to the use of silicon solar cells. The company is offering licenses for the use of the CIGSolar® process technology, and plans to generate revenue through licensing fees and manufacturing royalties for the use of the CIGSolar® technology.
For more information please call XsunX at 888-797-4527, or visit the company's website at www.xsunx.com.
Safe Harbor Statement
Matters discussed in this press release contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Company's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "may," "will," "should," "believes," "expect," "intend," "anticipate," "plan," "estimate" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject to risks and uncertainties that are described in our most recent annual report on Form 10-K under the heading "Risk Factors" and our subsequent filings with the Securities and Exchange Commission. We do not undertake any obligation to update publicly any forward-looking statements whether as a result of the receipt of new information, future events, or otherwise.
Contact:
XsunX
888-797-4527
www.xsunx.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Grupo Simec 2026 Nine-Month Financial Surge Spells Change

Sharp Climb in Net Income Sparks Interest Buckle up, folks. Grupo Simec's nine-month results for 2026 are a mixed bag of surprises and steady flows. Let’s break it down: the net income skyrocketed by a whopping 428% compared to the same period last year—jumping from Ps. 763 million to Ps. 4,028 million. That's a solid leap, and it’s largely due to turning a hefty...

Cloopen Group's Private Transition: What Investors Should Know

Cloopen Steps Away from Public Market Scene Here's a tale simmering on the corporate backburner: Cloopen Group Holding Limited, that cloud juggernaut over in China, has gone all private on us. The ink is drying on their merger with SummerX Holdings Limited, under the overarching umbrella of SpringX Holdings. So, now this communications outfit has slipped out of the public...

LanguageLine AI App Earns Vizient Technology Kudos

Tech Talk: LanguageLine's AI App Gains Important Recognition Diving headfirst into the chaotic world of healthcare, LanguageLine's AI Translation App earned a standout accolade. Just announced, it's snagged the Innovative Technology Designation from Vizient, the heavyweight champ in healthcare performance improvement. On the scene since the end of October, they rolled the...

Core Lab's Quarterly Grit: Navigating a Turbulent Market

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Freddy’s Joins Hershey For a Limited-Time Flavor Fest

The Sweet Collaboration We Didn't See Coming Well, folks, here's a tasty twist for you—Freddy's Frozen Custard & Steakburgers is cozying up to The Hershey Company to bring a sugar rush to our mundane lives. Starting Nov. 4, they're rolling out a limited-time series of treats so indulgent you'll want to skip straight to dessert. And if that wasn't enough, they're...

Bloomberg Law Integrates Docket Data with AI Platform

Bloomberg Law's Game-Changer for Legal Pros Here's something that'll make legal eagles perk up on this fine day: Bloomberg Law has rolled out a connector for Claude, marrying court dockets and litigation smarts to AI. Let's face it, the legal world always runs on precision and timing above all. So when an integration like this drops, it ain’t just a memo on the office...

AppLovin Faces Class Action: AI Growth Claims Under Fire

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Genedata's New ELN Transforms Biopharma R&D Workflows

Revolutionizing Research with a New Digital Tool Genedata, the brain behind enterprise software for drug discovery, has thrown a curveball into the world of biopharmaceutical research by launching a pioneering electronic lab notebook (ELN). This isn’t just another software update; it's a complete shift in how R&D workflows are structured and maintained. With an...

J.H. Strain & Sons' Asset Sale Seals a New Era

Texan Legacy Bows Out of the Asphalt Game Here's a fresh chapter in the world of road construction that'll have folks in the industry doing a double-take. Elder Bray & Bankler, a bigwig among corporate law circles, has been guiding this tale. They've shepherded J.H. Strain & Sons through selling off its asphalt manufacturing and construction assets to none other than...

Motiva's Q3 2026 Results: Strategic Moves Drive Growth

Strategic Transactions and Financial Highlights Motiva's third quarter of 2026 shows a company not just coasting but recalibrating its trajectory. Big moves had ripple effects on their financial landscape, most notably their sale of the Airport Platform, concluded for a hefty R$5.2 billion. Their portfolio's trimming isn't just a garage sale but a thought-out step...